<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Climbviolet5</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Climbviolet5"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Climbviolet5"/>
		<updated>2026-04-19T23:09:51Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=The_phosphorylation_of_IGF1_and_insulin_receptors_was_higher_in_IGF2-high_carcinoma_than_in_IGF2-low_carcinoma&amp;diff=148831</id>
		<title>The phosphorylation of IGF1 and insulin receptors was higher in IGF2-high carcinoma than in IGF2-low carcinoma</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_phosphorylation_of_IGF1_and_insulin_receptors_was_higher_in_IGF2-high_carcinoma_than_in_IGF2-low_carcinoma&amp;diff=148831"/>
				<updated>2017-03-06T16:44:53Z</updated>
		
		<summary type="html">&lt;p&gt;Climbviolet5: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Clients obtained equivalent treatment regimens (surgical procedure by itself or surgical treatment + mitotane) and Determine 2. Quantitative expression of IGF signaling pathway associates. Boxplots displaying the mRNA (quantitative RT-PCR) and/or protein (western blot) ranges of a number of IGF2 pathway members in IGF2-substantial (n = 23 for RT-PCR and n = 10 for western blot) and IGF2-minimal (n = ten) ACC. Y-axis for mRNA: consequence of the DDCT method (2-DDCT worth), with RNA18S5 as a reference gene. Y-axis for protein: results of the quantification of the western blot bands, normalized to actin. Wilcoxon examination benefits (p,.05 p,.01 p,.00 NS = not important) are indicated for each and every mRNA or protein studied. A: IGF2 and its receptors. B: Erk and Akt. C: other IGF2 pathway members with substantially different expression between IGF2-large and IGF2low ACC overexpression of IGF2 has no main effect on the expression of the associates of its signaling pathway. We then examined whether the activation of the IGF, Erk, and Akt pathways was diverse in between IGF2-substantial and IGF2-lower ACC. We assessed the abundance of the phosphorylated types of these proteins in ten tumors from every group by western blotting. The phosphorylation of IGF1 and insulin receptors was higher in IGF2-large carcinoma than in IGF2-low carcinoma, but there was no distinction in the phosphorylation status of Akt and Erk1/two when normalizing to whole Akt or Erk1/two respectively (Figure three) or actin (info not demonstrated). These benefits are very shocking due to the fact the larger expression of IGF2 in IGF2-substantial ACC ought to result in a strong stimulation of these two pathways. We are not able to exclude that the residual expression of IGF2 in IGF2-reduced ACC may possibly encourage these pathways, although this is not likely. An additional clarification is that other progress aspects or their receptors are a lot more expressed in IGF2-low tumors than in IGF2-higher tumors. Certainly, our comparison of the transcriptome amongst IGF2-high and IGF2-low ACC determined some progress aspects (FGF9, PDGFA, TNFSF10, and TNFSF4) that have been two-fold much more expressed in IGF2-low ACC than in IGF2-substantial ACC (underlined in yellow in Table S3_ACC_genes). Differential expressions of FGF9 and PDGFA have been verified by quantitative RT-PCR (Table S6).We carried out equivalent [http://www.zangjw.com.cn/comment/html/?138312.html For instance we were not able to control for elements this sort of as weight problems and insulin resistance] experiments in H295R clones. INSR/ IGF1R phosphorylation was unaffected by IGF2 knock-down (Determine S2A). Additionally, Erk and Akt pathways (Figure S2D-G) have been not inhibited. Surprisingly, we observed a considerable stimulation of Erk1/two phosphorylation after seven and 10 times of IGF2 knock-down. These results prompted us to evaluate the tumorigenic position of IGF2 in adrenocortical cells.The steady knock-down of IGF2 drastically impaired mobile proliferation in an MTT assay (Determine 4A), while cell proliferation was not influenced in a doxycycline-dealt with control clone (Determine 4B). This effect was obvious as before long as four times after the initiation of doxycycline remedy, and was maximal at D14. At this time stage, the number of cells of clone 4 taken care of with doxycycline was two.4 occasions lower than the variety of cells not taken care of with doxycycline (67666.seven without having Dox as opposed to 288613 with Dox, p,.001).&lt;/div&gt;</summary>
		<author><name>Climbviolet5</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=The_phosphorylation_of_IGF1_and_insulin_receptors_was_higher_in_IGF2-high_carcinoma_than_in_IGF2-low_carcinoma&amp;diff=148823</id>
		<title>The phosphorylation of IGF1 and insulin receptors was higher in IGF2-high carcinoma than in IGF2-low carcinoma</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_phosphorylation_of_IGF1_and_insulin_receptors_was_higher_in_IGF2-high_carcinoma_than_in_IGF2-low_carcinoma&amp;diff=148823"/>
				<updated>2017-03-06T16:35:59Z</updated>
		
		<summary type="html">&lt;p&gt;Climbviolet5: Створена сторінка: The prevalence of metastasis was also related. Clients obtained comparable remedy regimens (medical procedures by itself or surgical procedure + mitotane) and F...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The prevalence of metastasis was also related. Clients obtained comparable remedy regimens (medical procedures by itself or surgical procedure + mitotane) and Figure two. Quantitative expression of IGF signaling pathway users. Boxplots exhibiting the mRNA (quantitative RT-PCR) and/or [http://fanoctaviatour.ro/forum/index.php?p=/discussion/253514/the-disruption-of-the-cell-membrane-brought-on-the-leakage-of-cellular-content-inhibition-of-the-pro#Item_1 The disruption of the mobile membrane triggered the leakage of mobile content material inhibition of the proton pump respiratory chain electron transfer and oxidative phosphorylation] protein (western blot) amounts of several IGF2 pathway members in IGF2-substantial (n = 23 for RT-PCR and n = ten for western blot) and IGF2-reduced (n = ten) ACC. Y-axis for mRNA: outcome of the DDCT approach (2-DDCT value), with RNA18S5 as a reference gene. Y-axis for protein: outcomes of the quantification of the western blot bands, normalized to actin. Wilcoxon take a look at outcomes (p,.05 p,.01 p,.00 NS = not significant) are indicated for every mRNA or protein researched. A: IGF2 and its receptors. B: Erk and Akt. C: other IGF2 pathway customers with considerably diverse expression in between IGF2-high and IGF2low ACC overexpression of IGF2 has no main result on the expression of the associates of its signaling pathway. We then examined no matter whether the activation of the IGF, Erk, and Akt pathways was distinct in between IGF2-large and IGF2-lower ACC. We assessed the abundance of the phosphorylated kinds of these proteins in ten tumors from every group by western blotting. The phosphorylation of IGF1 and insulin receptors was larger in IGF2-high carcinoma than in IGF2-low carcinoma, but there was no big difference in the phosphorylation status of Akt and Erk1/2 when normalizing to total Akt or Erk1/2 respectively (Determine three) or actin (info not proven). These benefits are really surprising since the higher expression of IGF2 in IGF2-high ACC should outcome in a sturdy stimulation of these two pathways. We can not exclude that the residual expression of IGF2 in IGF2-low ACC may stimulate these pathways, even though this is unlikely. One more explanation is that other progress variables or their receptors are much more expressed in IGF2-low tumors than in IGF2-high tumors. Without a doubt, our comparison of the transcriptome amongst IGF2-substantial and IGF2-lower ACC discovered some progress elements (FGF9, PDGFA, TNFSF10, and TNFSF4) that have been 2-fold much more expressed in IGF2-reduced ACC than in IGF2-large ACC (underlined in yellow in Desk S3_ACC_genes). Differential expressions of FGF9 and PDGFA ended up verified by quantitative RT-PCR (Table S6).We carried out comparable experiments in H295R clones. INSR/ IGF1R phosphorylation was unaffected by IGF2 knock-down (Figure S2A). Moreover, Erk and Akt pathways (Determine S2D-G) have been not inhibited. Surprisingly, we noticed a considerable stimulation of Erk1/2 phosphorylation after seven and ten times of IGF2 knock-down. These outcomes prompted us to assess the tumorigenic function of IGF2 in adrenocortical cells.The stable knock-down of IGF2 substantially impaired cell proliferation in an MTT assay (Determine 4A), while mobile proliferation was not affected in a doxycycline-taken care of management clone (Determine 4B). This effect was apparent as quickly as four days after the initiation of doxycycline treatment, and was maximal at D14. At this time stage, the amount of cells of clone four handled with doxycycline was 2.4 moments reduced than the number of cells not handled with doxycycline (67666.seven with out Dox compared to 288613 with Dox, p,.001).&lt;/div&gt;</summary>
		<author><name>Climbviolet5</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=In_particular,_G4_ligand_treatment_of_telomerase-positive_glioma_cell_lines_resulted_in_telomere_instability,_cell_cycle_alterations_and_apoptosis_in_a_telomere_lengthindependent_manner&amp;diff=146948</id>
		<title>In particular, G4 ligand treatment of telomerase-positive glioma cell lines resulted in telomere instability, cell cycle alterations and apoptosis in a telomere lengthindependent manner</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=In_particular,_G4_ligand_treatment_of_telomerase-positive_glioma_cell_lines_resulted_in_telomere_instability,_cell_cycle_alterations_and_apoptosis_in_a_telomere_lengthindependent_manner&amp;diff=146948"/>
				<updated>2017-03-01T14:29:19Z</updated>
		
		<summary type="html">&lt;p&gt;Climbviolet5: Створена сторінка: A significant variation in CBF was observed throughout the complete cohort at 1 hour, 24 several hours and thirty hours put up-treatment method (p0.0001). By 30...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;A significant variation in CBF was observed throughout the complete cohort at 1 hour, 24 several hours and thirty hours put up-treatment method (p0.0001). By 30 hrs put up-treatment, equally the three mM and 30 mM teams showed a significant reduction in CBF in comparison to the untreated group (p0.01) (Determine 6C). Cilia idea distance was also calculated in ependymal cultures and similarly confirmed a substantial difference throughout the entire cohort at one hour, 24 hrs and 30 hrs put up-treatment (p0.0001). By 24 hrs publish-remedy, equally the three mM and 30 mM group showed a substantial reduction in cilia suggestion length in comparison to the untreated group (p0.01). (Figure 6D). These experiments collectively display that neural and endothelial cells show dosedependent sensitivity to RHPS4.Right here we existing a rationale for employing G4 ligands for the treatment of specific childhood and grownup mind tumors using RHPS4 as proof-of-idea of this class of anti-tumor agent and system of G4 ligand motion. Approaches to inhibit telomerase have normally focused on targeting the human telomerase reverse transcriptase (hTERT) and human telomerase RNA (hTR) parts of the telomerase enzyme [44,45,forty six,47]. Anti-cancer phenotypes resulting from this technique are noticed when 1 or a lot more telomeres turn into critically brief owing to an absence of telomerase-mediated telomere upkeep, manifesting in senescence or apoptosis. As a telomere duration-dependent lag may effect on the time to growth arrest in malignant cells, direct disruption of telomere structure whereby proliferation is arrested swiftly is an appealing method. Our outcome is steady with earlier scientific studies that unsuccessful to observe telomere reduction in tumor cells following RHPS4 publicity [seventeen,29]. Even so our information do not exclude the possibility that non-acute nanomolar doses of RHPS4 or .[http://bestofhousemusic.be/members/saltjury2/activity/208499/ The method also assists germs resist antibiotic peptides by regulating lipid A. Bivalent cations and antibiotic peptides can competitively bind to the acidic structural domain on the cytoplasmic surface of PhoQ] seventy two hour drug publicity might induce gradual telomere shortening connected in the long run with a senescent phenotype. In particular, G4 ligand treatment method of telomerase-good glioma cell traces resulted in telomere instability, cell cycle alterations and apoptosis in a telomere lengthindependent method, with IC50 values similar to these offered in our info [27]. Nevertheless, our data does not exclude the Determine 4. Acute RHPS4 exposure is related with telomerase inhibition in mind tumor cells in vitro. (A) Trap assay employing ethanolprecipitated telomere prolonged DNA goods following thirty minutes extension in non-drug handled brain tumor cells. Large stages of telomerase action are observed in each cell line. (B) Entice assays in RHPS4-dealt with brain tumor lysates reveals full telomerase inhibition in all cell traces at each drug concentration. .one mg of complete protein lysate was loaded for each nicely in each and every Lure assay. CHAPS, CHAPS buffer only no lysate control TS, telomere substrate inside management 61-bp oligonucleotide probability that telomerase inhibition at a subset of critically short telomeres could be required for RHPS4-mediated anti-proliferative consequences as we have assessed indicate telomere length inside of each tumor mobile line.&lt;/div&gt;</summary>
		<author><name>Climbviolet5</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=We_cannot_however_exclude_the_possibility_of_some_RHPS4_molecules_remaining_bound_to_the_telomere_substrate_after_ethanol_precipitation&amp;diff=146901</id>
		<title>We cannot however exclude the possibility of some RHPS4 molecules remaining bound to the telomere substrate after ethanol precipitation</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=We_cannot_however_exclude_the_possibility_of_some_RHPS4_molecules_remaining_bound_to_the_telomere_substrate_after_ethanol_precipitation&amp;diff=146901"/>
				<updated>2017-03-01T13:16:38Z</updated>
		
		<summary type="html">&lt;p&gt;Climbviolet5: We cannot however exclude the possibility of some RHPS4 molecules remaining bound to the telomere substrate after ethanol precipitation&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;A five moment telomere extension time period employing a telomere oligonucleotide substrate, permitted the synthesis of the minimal 4 hexameric TTAGGG telomere repeats needed for G4 ligands to stabilize a 4-stranded DNA composition (Figure 3B, C), prior to an added 25 minutes telomere extension [23]. PFSK-1 and DAOY showed reduced ranges of telomerase activity at low RHPS4 concentrations and complete absence of telomerase exercise at higher RHPS4 concentrations. In the same way C6 and GB-1 showed total absence of telomerase activity at equally RHPS4 concentrations analyzed (Figure 3D). Even so when RHPS4 was launched to mobile-totally free lysates right away on completion of 30 minutes telomere elongation but prior to the PCR amplification phase of the Entice assay, telomerase action was also absent and at all concentrations of drug analyzed (Figure 3E). Our results strongly point out that RHPS4 inhibits Taq polymerase throughout the PCR phase of the Trap assay and consequently RHPS4-mediated inhibition of telomerase activity can't be determined when the ligand is introduced possibly prior to or instantly following, telomere extension.Figure three. Telomere size measurement and RHPS4-mediated inhibition of Taq polymerase in vitro. (A) Mean TRF lengths for PFSK-1/ DAOY cells (three.8 kb/seven.8 kb) and C6/GB-1 (seven.five kb/three.9 kb) cells had been determined prior to RHPS4 publicity. (B) Quantitative Trap assay displaying telomerase-mediated telomere extension soon after 30 minutes (standard Entice assay) or five minutes extension time in non-drug uncovered cells. (C) PCR gel exhibiting telomere extension items soon after 5 minutes extension time in non-drug exposed cells. 1, no lysate control 2, PFSK-1, DAOY, C6 and GB-one. (D) PFSK-one and DAOY confirmed minimal levels of telomerase action at low RHPS4 concentrations and comprehensive absence of action at large RHPS4 concentrations, when RHPS4 was added pre-telomere extension. C6 and GB-one confirmed comprehensive absence of telomerase activity at the two RHPS4 concentrations analyzed. (E) Telomerase exercise was absent in all mobile lines and at equally RHPS4 concentrations when RHPS4 was added post-telomere extension. CHAPS, CHAPS buffer only no lysate handle IC, inner handle 61-bp telomere substrate oligonucleotide. To evaluate potential adverse mobile toxicity on RHPS4 remedy, mouse cerebellar progenitor cells and human mind endothelial cells ended up analyzed for viability following an acute three-day exposure to RHPS4. Both cell traces ended up sensitive to RHPS4 under these conditions, with an IC50 of fifteen mM and five mM respectively (Figure 6A, B). To better elucidate what consequences RHPS4 may have on the practical capability of neural cells, we utilized an ependymal society system ex vivo as a measure of neural mobile function based mostly on ependymal cilia. Major rat ependymal cultures ended up assessed for practical impairment of ependymal CBF and cilia suggestion length soon after 3 mM or 30 mM RHPS4 publicity relative to untreated cultures.&lt;br /&gt;
&lt;br /&gt;
We can't nonetheless exclude the likelihood of some RHPS4 molecules remaining bound to the telomere substrate soon after ethanol precipitation, thus impeding hybridization with telomere-particular primers and ensuing in an overestimation of telomerase inhibition.Determine 2. Acute RHPS4 exposure alters mobile cycle dynamics of brain tumor cells in vitro. PFSK-one cells exhibited a dose-dependent boost in the proportion of cells in G1-phase. In contrast DAOY, C6 and GB-one cells exhibited a dose-dependent increase in the proportion of cells in S-stage. PFSK-1 additional demonstrates a moderate accompanying enhance of sub-G0/1 cells at the increased RHPS4 concentration (five mM). Percentages are the imply from three independent experiments. Asterisk denotes a substantial distinction relative to untreated cells.To examine no matter whether other G-rich genomic sequences are vulnerable to RHPS4, activated c-Myc protein ranges have been assessed on publicity to RHPS4 utilizing the TransAMTM c-Myc assay. The c-Myc protein was selected on the basis that deregulation of c-Myc has been implicated in the origin of diverse human cancers and the c-Myc gene includes a G-abundant promoter sequence [forty two,43]. Jurkat tumor cell nuclear extracts show activation of c-Myc proportional to concentration of extract analyzed verifying the sensitivity of the TransAMTM c-Myc assay. A wild-type consensus oligonucleotide competitively binds to cMyc, whilst a mutant oligonucleotide has no distinctive effect, collectively demonstrating the specificity of the assay (Figure 5A). PFSK-one and C6 cells ended up selected for representative analyses as these lines differed in RHPS4 sensitivity by ,ten-fold (Figure 1A and C). PFSK-one cells taken care of with RHPS4 did not present a significant reduction in c-Myc activation at all drug concentrations analyzed relative to untreated motor vehicle-only controls (Figure 5B) (p0.05). Similarly, c-Myc activation levels at every RHPS4 concentration (1.00. mM) were equivalent to untreated controls in C6 cells (Determine 5C) (p0.76). In the two PFKS-one and C6 cells, specificity for c-Myc expression was confirmed by addition of the wild-sort oligonucleotide competitor throughout the assay c-Myc expression stages were considerably reduced when this inhibitor was added to untreated cells (Determine 5B, C p0.02). In addition, no reduction in c-Myc gene expression ranges as established by quantitative reverse transcriptase PCR, have been observed in both PFSK-one or C6 RHPS4-taken care of cells relative to untreated cells (Determine 5D, E). These results collectively suggest that RHPS4 sensitivity is not immediately connected with downregulated c-Myc stages in brain tumor cells in vitro when taking into consideration RHPS4 sensitivities following .seventy two hour exposure inside of these mobile lines.To evaluate the results of G4 stabilization straight at the telomere substrate, we launched RHPS4 straight into cell-free Trap assays using drug-dealt with protein/RNA lysates in purchase to discriminate no matter whether RHPS4-mediated inhibition of telomerase excludes inhibition of Taq polymerase by this G4 ligand.&lt;/div&gt;</summary>
		<author><name>Climbviolet5</name></author>	</entry>

	</feed>